L

Lupin Limited

Healthcare|Niftymidcap50
LUPIN-EQ: NSEBSE: 10440

Lupin Limited (LUPIN-EQ) live share price today at NSE / BSE

INR 2,098.10
+53.10 (2.6%)1 Day

Thu, 17 Sept 2026, 02:29 PM

About LUPIN-EQ

Lupin Ltd is a globally integrated pharmaceutical company headquartered in Mumbai, India. Established in 1968, Lupin is renowned for developing, manufacturing, and marketing a diversified portfolio of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company serves markets across North America, India, Europe, Asia-Pacific, Latin America, Middle East, and Africa, with a strong presence in cardiovascular, anti-diabetic, respiratory, central nervous system, and ophthalmic therapies. Lupin has built a robust global footprint through a combination of research-driven innovation, strategic acquisitions, and operational excellence. The company operates 15 manufacturing sites and eight R&D centers worldwide and maintains a consistent focus on compliance and quality. Lupin’s continued emphasis on access to affordable medicines and leadership in generics has established it among the top pharmaceutical companies in India and a notable supplier to major regulated markets.

52 Week Range

HighINR 2,529.50
LowINR 1,900.00

Current Signal

green

Open

INR 2,052.60

High

INR 2,098.10

Low

INR 2,046.30

Prev. Close

INR 2,045.00

Volume

5,25,909

Avg. Volume (7D)

6,80,864

Avg. Volume (10D)

6,62,932

Latest Signal

Buy

Buy Price

INR 2074.3

Close Price

INR 2098.1

Change

1.15%

Stoploss

INR 2012.1

Signal Date

2026-09-17

Hold

Yes

Pattern

Morning Star

Company Snapshot

CINL24100MH1983PLC029442
IndustryPharmaceuticals
Market Lot1
Impact Cost0.03%
Listing Date07 Oct 1993
BC Record DateRD 25/07/2025
Registered AddressKalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East)
AuditorBSR & Co. LLP, Chartered Accountants

Registrar

Name

MUFG Intime India Pvt. Ltd

Telephone

91 810 811 6767

Shareholding Pattern

Quarterly filing · 30 Jun 2026

Promoter & Promoter Group46.85%
Domestic Institutions9.73%
Non-Institutions6.42%
Foreign Institutions0.04%

Board of Directors

Mr.Alfonso ZuluetaNon-Executive - Independent Director
Mr.Amit Kumar GuptaCompany Secretary & Compliance Officer
Mr.Jeffrey KindlerNon-Executive - Independent Director
Mr.Kanwar Bir Singh AnandNon-Executive - Independent Director
Mr.Mark D. McDadeNon-Executive - Independent Director
Mr.Nilesh D. GuptaExecutive Director
Mr.Ramesh SwaminathanExecutive Director
Mr.Sunil MakhariaInterim Chief Financial Officer
Mrs.Manju D. GuptaNon-Executive - Non Independent Director-Chairperson related to Promoter
Ms.Punita Kumar-SinhaNon-Executive - Independent Director
Ms.Punita LalNon-Executive - Independent Director
Ms.Vinita GuptaExecutive Director

Today Share Price

Lupin Limited

ParticularsDetails
Opening PriceINR 2,052.60
Previous Closing PriceINR 2,045.00
Volume of Lupin Limited5,25,909
Value of Share

Today NSE Share Price

Lupin Limited

ParticularsDetails
Live Share Price NSE IndiaINR 2,098.10
Previous Closing PriceINR 2,045.00
Open PriceINR 2,052.60
HighINR 2,098.10
LowINR 2,046.30

Today BSE Share Price

Lupin Limited

ParticularsDetails
Live Share Price BSE IndiaINR 2,098.10
Previous Closing PriceINR 2,045.00
Open PriceINR 2,052.60
HighINR 2,098.10
LowINR 2,046.30

Lupin Limited

Lupin Ltd is a globally integrated pharmaceutical company headquartered in Mumbai, India. Established in 1968, Lupin is renowned for developing, manufacturing, and marketing a diversified portfolio of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company serves markets across North America, India, Europe, Asia-Pacific, Latin America, Middle East, and Africa, with a strong presence in cardiovascular, anti-diabetic, respiratory, central nervous system, and ophthalmic therapies. Lupin has built a robust global footprint through a combination of research-driven innovation, strategic acquisitions, and operational excellence. The company operates 15 manufacturing sites and eight R&D centers worldwide and maintains a consistent focus on compliance and quality. Lupin’s continued emphasis on access to affordable medicines and leadership in generics has established it among the top pharmaceutical companies in India and a notable supplier to major regulated markets.

Frequently Asked Questions – StockYaari Stock Page

Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.

Final Thoughts

Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.

Everything you need to trade, in one place

By proceeding, you agree to our T&C

Track. Analyse. Outperform.

Your performance, our priority.

Platform Performance

(vs NIFTY 50)

Total Return

+24.35%

Outperformance

+12.41%

Accuracy

78%

Started Now

Join 31,000+ active traders

unlock

Ready to unlock premium signals?

Sign in with your mobile number and start trading smarter today.

checkQuick & EasycheckSecure & ReliablecheckSEBI Registered